MoneyWorks4Me

Orchid Pharma - Quaterly Results

23 May 2024 Evaluate
The total revenue for the quarter ended March 2024 remained nearly unchanged at Rs. 2171.02 millions.Profit after Tax for the quarter ended March 2024 saw a decline of -49.66% from Rs. 659.31 millions to Rs. 331.87  millions.Operating profit for the quarter ended March 2024 rose to 418.10 millions as compared to 414.17 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 2171.02 2099.01 3.43 8193.68 6658.98 23.05 8193.68 6658.98 23.05
Other Income 128.85 17.29 645.23 303.89 194.30 56.40 303.89 194.30 56.40
PBIDT 418.10 414.17 0.95 1410.70 1030.49 36.90 1410.70 1030.49 36.90
Interest 34.47 74.84 -53.94 163.28 322.26 -49.33 163.28 322.26 -49.33
PBDT 383.63 731.43 -47.55 1247.42 1100.33 13.37 1247.42 1100.33 13.37
Depreciation 84.02 72.12 16.50 332.19 547.87 -39.37 332.19 547.87 -39.37
PBT 299.61 659.31 -54.56 915.23 552.46 65.66 915.23 552.46 65.66
TAX -32.26 0.00 0.00 -32.26 0.00 0.00 -32.26 0.00 0.00
Deferred Tax -32.26 0.00 0.00 -32.26 0.00 0.00 -32.26 0.00 0.00
PAT 331.87 659.31 -49.66 947.49 552.46 71.50 947.49 552.46 71.50
Equity 507.19 408.16 24.26 507.19 408.16 24.26 507.19 408.16 24.26
PBIDTM(%) 19.26 19.73 -2.40 17.22 15.48 11.25 17.22 15.48 11.25
Peers
Company Name CMP
Sun Pharma. Inds. 1851.50
Dr. Reddys Labs. 1140.50
Cipla 1357.95
Lupin 2041.60
Zydus Lifesciences 1098.40
View more..